The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Cannabinoid-receptor blocker will probably not be sold in the US

    The New York Times reports, “The [FDA] advisory panel voted unanimously, 14 to 0, against recommending the drug [rimonabant, Acomplia, Zimulti], saying there was inadequate evidence of its safety. The FDA is not required to follow this advice, but it typically does.”

    The report is interesting to this blog because rimonabant works by blocking cannabinoids receptors in the brain.

    Marijuana research shows that it “works on brain receptors to give users the ‘munchies.'” Clinical studies revealed that patients taking rimonabant lost about 5% of their weight.

    However, the Times article goes on to explain, the same brain system also modulates depression, phobias, anxiety, and post-traumatic stress disorder. And testimony during advisory meeting suggested that tampering with this system also increased such psychiatric symptoms, including suicidal thoughts.

    There was also an increase in suicidal thinking among users of the drug, including 4 patients who committed suicide while taking it.

    Derek Lowe has background and thoughts about rimonabant here.

    6/15/07 09:33 JR

    Leave a Comment

    XHTML: Line-breaks are automatic. Available tags are <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>